|
421 |
Wirksamkeit von Teprotumumab bei der chronischen endokrinen Orbitopathie
Enthalten in Kompass Autoimmun Bd. 6, 2024, Nr. 2: 81-82. 2 S.
|
|
|
|
422 |
Systemischer Lupus erythematodes: Neue Hoffnung durch Baricitinib-Therapie?
Enthalten in Kompass Autoimmun Bd. 6, 2024, Nr. 2: 74-76. 3 S.
|
|
|
|
423 |
Morbus Crohn: Vielversprechende Behandlungsoption eines neuen IL-23-Inhibitors auf dem Weg zur Zulassung
Enthalten in Kompass Autoimmun Bd. 6, 2024, Nr. 2: 66-69. 4 S.
|
|
|
|
424 |
Birmekizumab: Erweitert die Therapieoptionen besonders bei axialer Spondylarthritis
Enthalten in Kompass Autoimmun Bd. 6, 2024, Nr. 2: 64-65. 2 S.
|
|
|
|
425 |
Colitis ulcerosa: Zur Behandlung einer Anämie ist die Wirksamkeit von Spirulina-Supplement noch nicht ausreichend belegt
Enthalten in Kompass Autoimmun Bd. 6, 2024, Nr. 1: 17-18. 2 S.
|
|
|
|
426 |
Local and global effects of sedation in resting-state fMRI: a randomized, placebo-controlled comparison between etifoxine and alprazolam
Enthalten in Neuropsychopharmacology 31.5.2024: 1-11
|
|
|
|
427 |
Ingestion of β-nicotinamide mononucleotide increased blood NAD levels, maintained walking speed, and improved sleep quality in older adults in a double-blind randomized, placebo-controlled study
Enthalten in GeroScience 24.5.2024: 1-18
|
|
|
|
428 |
Saccharomyces boulardii improves clinical and paraclinical indices in overweight/obese knee osteoarthritis patients: a randomized triple-blind placebo-controlled trial
Enthalten in European journal of nutrition 18.5.2024: 1-15
|
|
|
|
429 |
Efficacy of Chinese Medicine Treatment Based on Syndrome Differentiation for Primary Insomnia: A Randomized Placebo Controlled Triple-Blinded Trial
Enthalten in Chinese journal of integrative medicine 16.5.2024: 1-10
|
|
|
|
430 |
Immunomodulating effects of the single bacterial strain therapy EDP1815 on innate and adaptive immune challenge responses — a randomized, placebo-controlled clinical trial
Enthalten in Immunologic research 15.5.2024: 1-12
|
|
Administration
